120 related articles for article (PubMed ID: 8104684)
1. Effect of the peroxisome proliferator perfluorodecanoic acid on the promotion of two-stage hepatocarcinogenesis in rats.
Borges T; Peterson RE; Pitot HC; Robertson LW; Glauert HP
Cancer Lett; 1993 Aug; 72(1-2):111-20. PubMed ID: 8104684
[TBL] [Abstract][Full Text] [Related]
2. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP
Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745
[TBL] [Abstract][Full Text] [Related]
3. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats.
Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP
Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245
[TBL] [Abstract][Full Text] [Related]
4. Perfluorodecanoic acid noncompetitively inhibits the peroxisomal enzymes enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase.
Borges T; Glauert HP; Robertson LW
Toxicol Appl Pharmacol; 1993 Jan; 118(1):8-15. PubMed ID: 8430427
[TBL] [Abstract][Full Text] [Related]
5. Formation of 8-oxodeoxyguanosine in liver DNA and hepatic injury by peroxisome proliferator clofibrate and perfluorodecanoic acid in rats.
Kim SC; Hong JT; Jang SJ; Kang WS; Yoo HS; Yun YP
J Toxicol Sci; 1998 May; 23(2):113-9. PubMed ID: 9644651
[TBL] [Abstract][Full Text] [Related]
6. Effect of the peroxisome proliferator perfluorodecanoic acid on growth and lipid metabolism in Sprague Dawley rats fed three dietary levels of selenium.
Borges T; Glauert HP; Chen LC; Chow CK; Robertson LW
Arch Toxicol; 1990; 64(1):26-30. PubMed ID: 2306190
[TBL] [Abstract][Full Text] [Related]
7. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats.
Glauert HP; Srinivasan S; Tatum VL; Chen LC; Saxon DM; Lay LT; Borges T; Baker M; Chen LH; Robertson LW
Biochem Pharmacol; 1992 Mar; 43(6):1353-9. PubMed ID: 1562286
[TBL] [Abstract][Full Text] [Related]
8. Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal beta-oxidation by peroxisome proliferators.
Vanden Heuvel JP; Sterchele PF; Nesbit DJ; Peterson RE
Biochim Biophys Acta; 1993 Jun; 1177(2):183-90. PubMed ID: 8499488
[TBL] [Abstract][Full Text] [Related]
9. Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels.
Kawashima Y; Kobayashi H; Miura H; Kozuka H
Toxicology; 1995 May; 99(3):169-78. PubMed ID: 7610463
[TBL] [Abstract][Full Text] [Related]
10. Dose-related effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal beta-oxidation.
Borges T; Robertson LW; Peterson RE; Glauert HP
Arch Toxicol; 1992; 66(1):18-22. PubMed ID: 1580792
[TBL] [Abstract][Full Text] [Related]
11. Induction of hepatic acyl-CoA-binding protein and liver fatty acid-binding protein by perfluorodecanoic acid in rats. Lack of correlation with hepatic long-chain acyl-CoA levels.
Sterchele PF; Vanden Heuvel JP; Davis JW; Shrago E; Knudsen J; Peterson RE
Biochem Pharmacol; 1994 Aug; 48(5):955-66. PubMed ID: 8093108
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine.
Pitot HC; Goldsworthy T; Campbell HA; Poland A
Cancer Res; 1980 Oct; 40(10):3616-20. PubMed ID: 6108157
[TBL] [Abstract][Full Text] [Related]
13. Effect of dietary vitamin E on the development of altered hepatic foci and hepatic tumors induced by the peroxisome proliferator ciprofibrate.
Glauert HP; Beaty MM; Clark TD; Greenwell WS; Tatum V; Chen LC; Borges T; Clark TL; Srinivasan SR; Chow CK
J Cancer Res Clin Oncol; 1990; 116(4):351-6. PubMed ID: 1975253
[TBL] [Abstract][Full Text] [Related]
14. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethylnitrosamine.
Glauert HP; Beer D; Rao MS; Schwarz M; Xu YD; Goldsworthy TL; Coloma J; Pitot HC
Cancer Res; 1986 Sep; 46(9):4601-6. PubMed ID: 2873887
[TBL] [Abstract][Full Text] [Related]
15. Perfluoro-n-decanoic acid: induction of peroxisomal beta-oxidation by a fatty acid with dioxin-like toxicity.
Harrison EH; Lane JS; Luking S; Van Rafelghem MJ; Andersen ME
Lipids; 1988 Feb; 23(2):115-9. PubMed ID: 3367697
[TBL] [Abstract][Full Text] [Related]
16. Increased 8-hydroxydeoxyguanosine in hepatic DNA of rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
Huang CY; Wilson MW; Lay LT; Chow CK; Robertson LW; Glauert HP
Cancer Lett; 1994 Dec; 87(2):223-8. PubMed ID: 7812944
[TBL] [Abstract][Full Text] [Related]
17. Dose-response hapatotoxicity of the peroxisome proliferator, perfluorodecanoic acid and the relationship to phospholipid metabolism in rats.
Adinehzadeh M; Reo NV; Jarnot BM; Taylor CA; Mattie DR
Toxicology; 1999 Jun; 134(2-3):179-95. PubMed ID: 10403636
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of long-chain acyl-CoA synthetase by the peroxisome proliferator perfluorodecanoic acid in rat hepatocytes.
Vanden Heuvel JP; Kuslikis BI; Shrago E; Peterson RE
Biochem Pharmacol; 1991 Jul; 42(2):295-302. PubMed ID: 1859447
[TBL] [Abstract][Full Text] [Related]
19. Lack of initiating activity of the peroxisome proliferator ciprofibrate in two-stage hepatocarcinogenesis.
Glauert HP; Clark TD
Cancer Lett; 1989 Feb; 44(2):95-100. PubMed ID: 2920376
[TBL] [Abstract][Full Text] [Related]
20. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver.
Cattley RC; Popp JA
Cancer Res; 1989 Jun; 49(12):3246-51. PubMed ID: 2566380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
